Platelet activation and subsequent aggregation is a vital component of atherothrombosis resulting in acute myocardial infarction. Therefore, quantifying platelet aggregation is a valuable measure for elucidating the pathogenesis of acute coronary syndromes (ACS). Circulating platelet-monocyte conjugates (PMC) as determined by flow cytometry (FCM) are an important measure of in vivo platelet aggregation. However, the influence of sample handling on FCM measurement of PMC is not well-studied. The changes in FCM measurement of PMC with variation in sample handling techniques were evaluated. The stability of PMC concentrations over time with changes in fixation and immunolabeling intervals was assessed. The effect of Time-to-Fix and Time-to-Stain on FCM PMC measurements was investigated in five healthy volunteers. Time-to-Fix (i.e., interval between phlebotomy and sample fixation) was performed at 3, 30, and 60 min. Time-to-Stain (i.e., time of fixed sample storage to staining) was performed at 1, 24, and 48 h. Increasing Time-to-Stain from 1 to 24 or 48 h resulted in lower PMC measures (p < 0.0001). A statistically significant difference in PMC measurement with increasing Time-to-Fix was not observed (p < 0.41). Postponement of sample staining has deleterious effects on the measurement of PMC via FCM. Delays in immunolabeling of fixed samples compromised measurement of PMC by 30% over the first 24 h. Staining/FCM should be completed within an hour of collection.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Libby P (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104(3):365–372
Freedman JE, Loscalzo J (2002) Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 105(18):2130–2132
Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM et al (2001) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38(4):1002–1006
Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J et al (1996) In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 93(21):11877–11882
Hui H, Fuller K, Erber WN, Linden MD (2015) Measurement of monocyte-platelet aggregates by imaging flow cytometry. Cytometry A 87(3):273–278
Linden MD (2013) Platelet flow cytometry. Methods Mol Biol 992:241–262
Michelson AD (1996) Flow cytometry: a clinical test of platelet function. Blood 87(12):4925–4936
Michelson AD (2006) Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 35(1–2):67–82
Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70(1):307–315
Ault KA (2001) The clinical utility of flow cytometry in the study of platelets. Semin Hematol 38(2):160–168
Harding SA, Din JN, Sarma J, Jessop A, Weatherall M, Fox KA et al (2007) Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost 98(2):451–456
Shattil S (1991) Use of monoclonal antibodies for the detection and analysis of activated human platelets. Curr Stud Hematol Blood Transfus 58:26–31
Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104(13):1533–1537
Sarma J, Laan CA, Alam S, Jha A, Fox KA, Dransfield I (2002) Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105(18):2166–2171
Wang J, Zhang S, Jin Y, Qin G, Yu L, Zhang J (2007) Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. Int J Cardiol 115(3):361–365
Linden MD, Frelinger AL 3rd, Barnard MR, Przyklenk K, Furman MI, Michelson AD (2004) Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30(5):501–511
Hu H, Daleskog M, Li N (2000) Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding. Thromb Res 100(3):161–166
Loken MR, Brosnan JM, Bach BA, Ault KA (1990) Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11(4):453–459
Knapp W, Rieber P, Dorken B, Schmidt RE, Stein H, Borne AE (1989) Towards a better definition of human leucocyte surface molecules. Immunol Today. 10(8):253–258
Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326(4):242–250
Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326(5):310–318
Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378–3384
DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK et al (2019) Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation 140(20):1661–1678
DeFilippis AP, Nasir K, Blaha MJ (2019) Myocardial infarction as a clinical end point in research. Circ Res 124(12):1701–1703
Sultan A, Zheng Y, Trainor PJ, Siow Y, Amraotkar AR, Hill BG et al (2017) Circulating prolidase activity in patients with myocardial infarction. Front Cardiovasc Med 4:50
Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC et al (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31(2):352–358
Zeng S, Zhou X, Ge L, Ji WJ, Shi R, Lu RY et al (2014) Monocyte subsets and monocyte-platelet aggregates in patients with unstable angina. J Thromb Thrombolysis 38(4):439–446
Zhang SZ, Jin YP, Qin GM, Wang JH (2007) Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes. Clin Cardiol 30(1):26–31
Hui H, Fuller KA, Erber WN, Linden MD (2017) Imaging flow cytometry in the assessment of leukocyte-platelet aggregates. Methods 112:46–54
This study was financially supported by the American Heart Association (11CRP7300003) and National Institute of Health (1P20 GM103492-05). We thank Jacob Schultz, Mallory Hatfield, and Joey Shaw for their assistance with sample acquisition and processing; Aaron Puckett (UofL Diabetes and Obesity Center Core Lab) for helping with flow cytometry; Allison Smith for editing the manuscript; Yong Siow and Tim O’Toole for intellectual guidance.
American Heart Association (11CRP7300003) and National Institutes of Health (1P20 GM103492-05).
Conflict of interest
All authors have no conflict of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Singh, A., Coulter, A.R., Trainor, P.J. et al. Flow cytometric evaluation of platelet–leukocyte conjugate stability over time: methodological implications of sample handling and processing. J Thromb Thrombolysis (2020). https://doi.org/10.1007/s11239-020-02186-5
- Flow cytometry
- Specimen handling